The CD8+ CTL clonotype skew toward an exhausted transcriptomic signature that we observed after 1 mL DEN-181 resembles the impact of anti-CD3 or LFA3-Ig immunotherapy on CD8+ T cells in T1D (16). This evidence concerns the gene CD58 and type 1 diabetes mellitus.